Ocular Therapeutix™ to Participate in the 2018 Glaucoma 360 Meeting in San Francisco
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate in the 7th Annual Glaucoma 360 New Horizons Forum being held on Friday, February 9, 2018, at The Palace Hotel, in San Francisco. This meeting presented by Glaucoma Research Foundation brings together key clinical, industry, fin